Literature DB >> 32412709

Compassionate Use of Remdesivir in Covid-19. Reply.

Jonathan Grein1, Robert P Myers2, Diana Brainard2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32412709     DOI: 10.1056/NEJMc2015312

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Understanding COVID-19 Situation in Nepal and Implications for SARS-CoV-2 Transmission and Management.

Authors:  Prabin Dawadi; Gopiram Syangtan; Bhupendra Lama; Sushil R Kanel; Dev Raj Joshi; Lok R Pokhrel; Rameshwar Adhikari; Hem R Joshi; Ioana Pavel
Journal:  Environ Health Insights       Date:  2022-06-07

Review 2.  Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19.

Authors:  Kimberly Hall; Fuhbe Mfone; Michael Shallcross; Vikas Pathak
Journal:  Eurasian J Med       Date:  2021-06

3.  An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.

Authors:  Dongyuan Wang; Zigang Li; Yihui Liu
Journal:  J Infect Public Health       Date:  2020-07-13       Impact factor: 3.718

4.  [Remdesivir for patients with COVID-19].

Authors:  M Augustin; M Hallek; S Nitschmann
Journal:  Internist (Berl)       Date:  2020-08       Impact factor: 0.743

5.  Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.

Authors:  Carlo Tascini; Giovanni Sermann; Alberto Pagotto; Emanuela Sozio; Chiara De Carlo; Alessandro Giacinta; Francesco Sbrana; Andrea Ripoli; Nadia Castaldo; Maria Merelli; Barbara Cadeo; Cristiana Macor; Amato De Monte
Journal:  Intern Emerg Med       Date:  2020-11-01       Impact factor: 3.397

6.  Phylogenetic supertree reveals detailed evolution of SARS-CoV-2.

Authors:  Tingting Li; Dongxia Liu; Yadi Yang; Jiali Guo; Yujie Feng; Xinmo Zhang; Shilong Cheng; Jie Feng
Journal:  Sci Rep       Date:  2020-12-22       Impact factor: 4.379

7.  Significant liver injury during hospitalization for COVID-19 is not associated with liver insufficiency or death.

Authors:  Michael Chew; Zeyu Tang; Christopher Radcliffe; Dennis Caruana; Natty Doilicho; Maria M Ciarleglio; Yanhong Deng; Guadalupe Garcia- Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2021-05-15       Impact factor: 11.382

Review 8.  A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.

Authors:  Ramiro Picoli Nippes; Paula Derksen Macruz; Gabriela Nascimento da Silva; Mara Heloisa Neves Olsen Scaliante
Journal:  Process Saf Environ Prot       Date:  2021-06-30       Impact factor: 6.158

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.